New blood and urine tests could spot Drug-Related pancreatitis early

NCT ID NCT05279079

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at new markers in blood and urine to detect and predict the severity of drug-associated acute pancreatitis in adults. Researchers compared these markers in 175 patients with drug-induced pancreatitis, other pancreatic diseases, and healthy volunteers. The goal is to develop a faster, more accurate diagnostic tool.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a simple blood or urine test to quickly diagnose drug-induced pancreatitis and predict how severe it will be.
What could go wrong
This is an observational study, not a treatment trial. The biomarkers may not prove accurate enough for routine use, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE PANCREATITIS DRUG-INDUCED are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Aintree University Hospital

    Liverpool, Merseyside, L9 7AL, United Kingdom

  • Hospital Regional Universitario de Málaga

    Málaga, Málaga, 29010, Spain

  • LMU Klinikum München

    Munich, Bavaria, 81377, Germany

  • Royal Liverpool University Hospital

    Liverpool, Merseyside, L7 8XP, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.